Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |